Study reveals two proteins that may contribute to stroke recurrence or other MACEs
The life-threatening medical condition affects 100,000 people in the UK every year
Read More
Tag: Boston University School of Public Health
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
